Speaker Profile
Kathrin U. Jansen

Kathrin U. Jansen

Research and Clinical Research
New York, New York, United States of America

Connect with the speaker?

Dr. Kathrin Jansen is senior vice president of Vaccine Research and Early Development at Pfizer Inc and member Pfizer’s WRD leadership team. In 2006, Dr. Jansen joined Wyeth, now part of Pfizer, as senior vice president, responsible for leading vaccine research with a focus on infectious disease targets, early development and clinical testing. In this capacity, she and colleagues at Pfizer supported the pediatric licensure of Prevnar 13® and the adult licensure application of Prevnar 13, as well as the Community Acquired Pneumonia Immunization Trial for Adults (CAPiTA). In addition, she directed the Company's Neisseria meningitidis serogroup B vaccine efforts to develop a licensure strategy for the vaccine that led to the successful initiation of phase 3 clinical trials. Furthermore, she and her group developed vaccines against Staphylococcus aureus and Clostridium difficile that are in phase 2 (Staphylococcus aureus vaccine)and phase 1 (Clostridium difficile vaccine) clinical evaluation
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)